CVRx (CVRX) Moves 11.6% Higher: Will This Strength Last?
CVRx (CVRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks
More News
Why Steris (STE) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks
Why Is Steris (STE) Up 1% Since Last Earnings Report?
Steris (STE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
Are Options Traders Betting on a Big Move in STERIS Stock?
Investors need to pay close attention to STE stock based on the movements in the options market lately.
Zacks
Why Steris (STE) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks
Here's Why Steris (STE) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks
Reasons to Retain STE Stock in Your Portfolio for Now
STERIS' Healthcare and AST segments post solid gains and milestones, but FX volatility, tariffs and global macro pressures threaten earnings variability.
STERIS posts Q4 adjusted EPS of $2.83 and revenues of $1.59 billion, both slight misses; shares dip after hours despite broad growth and FY27 guidance.
Steris (STE) Q4 Earnings and Revenues Miss Estimates
Steris (STE) delivered earnings and revenue surprises of -0.88% and -0.47%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?